SOLIDARITY trials
COVID-19 treatment: SOLIDARITY trial is restarting with 3 drugs this time
The drug candidates for repurposing are imatinib, a cancer drug; infliximab, an antibody; and artesunate, an anti-malarial drug. The tests seek to explore possible drugs that can be repurposed to treat severely affected COVID-19 patients
WHO mega trial results out: Remdesivir, Interferon fail to prove effective
None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir
- Al-Qassam video depicts rescue of Israeli captives from IOF bombing in Gaza
- Eight wounded as Syrian-Lebanese border tension comes back to the fore
- Trump’s mass deportation operation escalates with workplace raids
- Jordan bans Muslim Brotherhood, confiscates its assets after alleged security plot
- Medics on hunger strike against Gaza genocide reach European Parliament
